结肠癌患者肿瘤组织中血管紧张素转换酶的基因多态性研究
被引量:5
出处
《肿瘤》
CAS
CSCD
北大核心
2010年第3期265-266,共2页
Tumor
基金
上海市浦东新区社会发展局2007年度卫生科技项目(编号:PW2007A-32)
参考文献10
-
1ROCKEN C,NEUMANN K,CARL M S,et al. The gene polymorphism of the angiotensin Ⅰ-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients [ J ]. Neoplasm ,2007,9 ( 9 ) :716-722. 被引量:1
-
2CHRISTIAN J B,LAPANE K L,HUME A L,et al. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial [ J ]. J Natl Cancer lnst ,2008,100( 17 ) : 1223-1232. 被引量:1
-
3NEO J H, MALCONTENTI-WILSON C, MURALIDHARAN V,et al. Effect of ACE inhibitors and angiotensin Ⅱ receptor antagonists in a mouse model of colorectal cancer liver metastases[J]. J Gastroenterol Hepato1,2007,22 (4) : 577-584. 被引量:1
-
4黄玮,钟捷.血管紧张素Ⅱ及其受体1在实体肿瘤中的研究进展[J].肿瘤,2007,27(2):162-163. 被引量:3
-
5VAN-DER-KNAAP R, SIEMES C, COEBERGH J W,et al. Reninangiotensin system inhibitors, angiotensin Ⅰ-converting enzyme gene insertion/deletion polymorphism,and cancer: the Rotterdam Study[J]. Cancer,2008,112(4) : 748-757. 被引量:1
-
6FREITAS-SILVA M, PEREIRA D, COELHO C, et al. Angiotensin Ⅰ-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women[ J]. Cancer Genct Cytogen,2004,155 ( 1 ) :42-46. 被引量:1
-
7VAIRAKTARIS E, YAPIJAKIS C, TSIGRIS C, et al. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer[ J]. Acta Oncol,2007,46 (8) : 1097-1102. 被引量:1
-
8HERR D, RODEWALD M, FRASER H M,et al. Potential role of renin-angiotensin-system for tumor angiogenesis in receptor negative breast cancer [ J ]. Gynecol Oncol, 2008,109 ( 3 ) :418-425. 被引量:1
-
9YAREN A, OZTOP I, TURGUT S,et al. Angiotensin-eonverting enzyme gene polymorphism is associated with anemia in non-small cell lung cancer[ J]. Exp Biol Med (Maywood), 2008, 233 (1) : 32-37. 被引量:1
-
10SUGIMOTO M, FURUTA T, SHIRAI N, et al. Influences of chymase and angiotensin Ⅰ -converting enzyme gene polymorphisms on gastric cancer risks in Japan[ J ]. Cancer Epidemiol Biomarkers Prey,2006,15(10) : 1929-1934. 被引量:1
二级参考文献21
-
1DESHAYES F,NAHMIAS C.Angiotensin receptors:a new role in cancer[J].Trends Endocrinol Metab,2005,16(7):293-299. 被引量:1
-
2DINH D T,FRAUMAN A G,SOMERS G R,et al.Evidence for activation of the renin-angiotensin system in the human prostate:increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia[J].J Pathol,2002,196(2):213-219. 被引量:1
-
3LAM K Y,LEUNG P S.Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours[J].Eur J Endocrinol,2002,146(4):567-572. 被引量:1
-
4de PAEPE B,VERSTRAETEN V L,de POTTER C R,et al.Growth stimulatory angiotensin Ⅱ type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma[J].Histochem Cell Biol,2001,116(3):247-254. 被引量:1
-
5TAKEDA H,KONDO S.Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression[J].Am J Pathol,2001,158(5):1633-1637. 被引量:1
-
6FUJIMOTO Y,SASAKI T,TSUCHIDA A,et al.Angiotensin Ⅱ type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin ⅡI type 1 receptor antagonist[J].FEBS Lett,2001,495(3):197-200. 被引量:1
-
7INO K,SHIBATA K,KAJIYAMA H,et al.Angiotensin Ⅱ type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival[J].Br J Cancer,2006,94(4):552-560. 被引量:1
-
8AMAYA K,OHTA T,KITAGAWA H,et al.Angiotensin Ⅱ activates MAP kinase and NF-kappaB through angiotensin Ⅱ type I receptor in human pancreatic cancer cells[J].Int J Oncol,2004,25(4):849-856. 被引量:1
-
9YASUMARU M,TSUJI S,TSUJII M,et al.Inhibition of angiotensin Ⅱ activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway[J].Cancer Res,2003,63(20):6726-6734. 被引量:1
-
10DAS U N.Is angiotensin-Ⅱ an endogenous pro-inflammatory molecule[J].Med Sci Monit,2005,11(5):RA155-162. 被引量:1
同被引文献41
-
1Takashi Fujimura,Tetsuo Ohta,Katsunobu Oyama,Tomoharu Miyashita,Koichi Miwa.Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: A review and report of personal experience[J].World Journal of Gastroenterology,2006,12(9):1336-1345. 被引量:33
-
2王楠,孙耕耘,张泓.血管紧张素转换酶2在大鼠肺微血管内皮细胞上的表达[J].安徽医科大学学报,2007,42(2):136-139. 被引量:6
-
3张凌云,于萍,刘云鹏,滕月娥,赵明芳,金波.肿瘤患者化疗期间的生活质量调查与分析[J].现代肿瘤医学,2007,15(6):860-862. 被引量:35
-
4Rcken C,Lendeckel U,Dierkes J,et al.The number of lymph node metastases in gastric cancer correlates with the angiotensin 1-converting enzyme gene insertion/deletion polymorphism[J].Clin Cancer Res.2005,11(7):2526-30. 被引量:1
-
5Van dan knaap R,Siemes C,Coebergh J W,et al.Renin-angiotensin system inhibitors,angiotensin Ⅰ-converting enzyme gene insertion/deletion polymorphism,and cancer:the Rotterdam Study[J].Cancer,2008,112(4):748-57. 被引量:1
-
6Freitas-Silva M,Pereira D,Coelho C,et al.Angiotensin Ⅰ-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women[J].Cancer Genet Cytogen,2004,155(1):42-6. 被引量:1
-
7Yaren A,Turgut S,Kursunluoglu R,et al.Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients[J].Tohoku J Exp Med,2006,210(2):109-16. 被引量:1
-
8Vairaktaris E,Yapijakis C,Tsigris C,et al.Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer[J].Acta Oncol,2007,46(8):1097-102. 被引量:1
-
9Herr D,Rodewald M,Fraser H M,et al.Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer[J].Gynecol Oncol,2008,109(3):418-25. 被引量:1
-
10Yaren A,Oztop I,Turgut S,et al.Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer[J].Exp Biol Med (Maywood),2008,233(1):32-7. 被引量:1
引证文献5
-
1纪树武,毛小东,刘菊梅,陈海泉,袁平,房志鹏,徐峰.食管癌患者血管紧张素转换酶基因多态性[J].安徽医科大学学报,2012,47(1):35-38. 被引量:2
-
2纪树武,毛小东,刘菊梅,陈海泉,袁平,房志鹏,徐峰.食管癌肿瘤组织血管紧张素转换酶基因多态性[J].中国医药指南,2012,10(16):1-2.
-
3侯安继,高红芳,胡艳,赵德民,茅佩娟.结直肠癌组织中血管紧张素转换酶基因多态性临床研究[J].肿瘤基础与临床,2014,27(6):467-469. 被引量:1
-
4郭东来,李鹏,韩振魁,斯坎德尔.努尔买买提.塞来昔布抑制人结肠癌细胞COLO205增殖及对COX-2、MMP-9mRNA表达影响的体外实验研究[J].临床和实验医学杂志,2015,14(16):1364-1367. 被引量:8
-
5杨慧.循证护理对消化系统肿瘤术后化疗患者生活质量和毒副作用的影响[J].中华现代护理杂志,2015,21(21):2532-2534. 被引量:11
二级引证文献22
-
1朱彤.脱氧核苷酸钠对晚期消化道肿瘤化疗患者免疫功能及毒副反应的影响[J].心理月刊,2018(2):183-184.
-
2彭丽娟,杜经纬,徐俊,常晋霞,胡为民,潘万龙.IL-12B基因多态性及血清表达水平与食管癌的关系[J].中国医药导报,2015,12(34):20-22.
-
3李花,任秀宝,马宝新,陈绍水,宁方玲,王振波.血管紧张素转化酶基因多态性与中国人群消化道肿瘤易感性的Meta分析[J].中国老年学杂志,2016,36(6):1367-1369. 被引量:2
-
4尚培中,柳勇,李永庆,张星光,张进权,南润玲,谷化平.COX-2和Gal-3表达与甲状腺乳头状癌浸润转移的关系[J].河北北方学院学报(自然科学版),2016,32(8):1-4. 被引量:6
-
5徐玲玲,王刚.循证护理和整体护理在手术室护理中的应用效果分析[J].实用临床医药杂志,2017,21(4):108-110. 被引量:83
-
6吴池华,李一,杨麟翰,黄婷,喻渊.双氢青蒿素作用于乳腺癌细胞抑制EMT和转移的作用及机制[J].临床和实验医学杂志,2017,16(13):1285-1288. 被引量:2
-
7郑盈盈,李同荟,王少雄.塞来昔布抗消化道肿瘤作用机制的研究进展[J].临床合理用药杂志,2017,10(23):176-178. 被引量:1
-
8杨昊,王玉平,张天明,张臻英,周永宁.COX-2抑制剂在胃癌中的研究进展[J].现代生物医学进展,2017,17(34):6773-6776. 被引量:1
-
9张吉.循证护理对肿瘤患者化疗后毒副作用及生活质量的影响[J].西南军医,2018,20(1):85-87. 被引量:4
-
10田金满,丹海永,史楠,张婧婧,张哲.循证护理在白血病患者化疗期间感染护理中的应用效果及对患者生活质量的影响[J].中华医院感染学杂志,2018,28(2):295-297. 被引量:97
-
1姜如同,王彦威,郭好学,郑瑞峰,刘书勇,张燕齐,杨巧枝.肺癌X刀治疗后血管紧张素转换酶的变化[J].中国肿瘤临床与康复,2003,10(1):31-32.
-
2侯安继,高红芳,胡艳,赵德民,茅佩娟.结直肠癌组织中血管紧张素转换酶基因多态性临床研究[J].肿瘤基础与临床,2014,27(6):467-469. 被引量:1
-
3杨璐,马韬,张晟,张晓非,陈美璇,张瑾.血管紧张素转换酶基因插入/缺失多态性与乳腺癌易感性的Meta分析[J].中国妇幼保健,2015,30(36):6426-6430. 被引量:1
-
4于书卿,赵继宗.血管紧张素转换酶基因插入/缺失多态性与颅内动脉瘤发病关系的研究[J].国际神经病学神经外科学杂志,2006,33(3):229-231. 被引量:4
-
5纪树武,毛小东,刘菊梅,陈海泉,袁平,房志鹏,徐峰.食管癌肿瘤组织血管紧张素转换酶基因多态性[J].中国医药指南,2012,10(16):1-2.
-
6纪树武,毛小东,刘菊梅,陈海泉,袁平,房志鹏,徐峰.食管癌患者血管紧张素转换酶基因多态性[J].安徽医科大学学报,2012,47(1):35-38. 被引量:2
-
7王玉兰.肺癌及肺部感染患者血清血管紧张素转换酶活性检测的意义[J].河南大学学报(医学科学版),2003,22(3):13-14. 被引量:3
-
8吴若飞,刘景晶.血管紧张素Ⅱ受体与肿瘤关系的研究进展[J].现代医学,2005,33(6):414-416. 被引量:1
-
9张玉玲,阎继锋,张舒林,黄振文,刘瑞云.血管紧张素转换酶基因插入/缺失多态性与PAI-1活性的相关性[J].中山大学学报(医学科学版),2004,25(6):594-597. 被引量:1
-
10史蕾,蒋莉莉,刘卫平,唐源.血管紧张素转换酶Ⅰ在肝局灶性结节状增生中的表达及其意义[J].中华病理学杂志,2006,35(7):421-422. 被引量:3